Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.20
-0.25 (-0.63%)
May 8, 2026, 1:58 PM CST

TPEX:7427 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6791,3741,4842,5621,823936
Market Cap Growth
4.57%-7.38%-42.09%40.55%94.83%-
Enterprise Value
1,2398838842,0631,731777
Last Close Price
39.1030.3932.2960.9752.0933.38
PS Ratio
1393.701140.63880.65528.303376.081485.29
PB Ratio
3.342.732.344.796.594.49
P/TBV Ratio
3.532.892.455.076.987.81
EV/Sales Ratio
-732.61524.33425.313205.061233.73
Debt / Equity Ratio
0.020.020.020.03--
Net Debt / Equity Ratio
-0.87-0.87-0.90-0.87-0.89-0.60
Net Debt / EBITDA Ratio
4.794.795.277.323.693.57
Net Debt / FCF Ratio
5.015.017.257.993.213.68
Asset Turnover
0.000.000.000.010.000.00
Inventory Turnover
0.460.460.15---
Quick Ratio
23.1923.1926.7729.9520.565.79
Current Ratio
24.1224.1227.4330.4720.875.80
Return on Equity (ROE)
-17.16%-17.16%-17.97%-15.04%-27.68%-21.80%
Return on Assets (ROA)
-10.46%-10.46%-11.51%-9.68%-16.58%-12.83%
Return on Capital Employed (ROCE)
-19.60%-19.60%-17.60%-12.10%-24.90%-17.50%
Earnings Yield
-5.80%-7.09%-7.07%-2.38%-3.68%-3.83%
FCF Yield
-5.23%-6.39%-5.32%-2.26%-4.23%-3.63%
Buyback Yield / Dilution
-4.82%-4.63%-13.60%-50.23%-14.54%-33.09%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.